Auna SAA
NYSE:AUNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Heritage Foods Ltd
NSE:HERITGFOOD
|
IN |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Country Average (622), the stock would be worth $0 (100% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0 | $5.15 |
0%
|
| Country Average | 622 | $0 |
-100%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| PE |
A
|
Auna SAA
NYSE:AUNA
|
380.9m USD | 0 | 0 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
308.9B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 3 417.4 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
102.4B ZAR | 14.3 | 10.6 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68.5B USD | -18 116.9 | 38 690 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
58.9B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
37.6B CHF | 0 | 0 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
37.6B USD | -4 415.5 | -3 332.7 | |
| US |
|
Coupang Inc
F:788
|
31.5B EUR | 31.9 | 174.3 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
30.1B ZAR | 17.6 | 6.9 |
Market Distribution
Other Multiples
Auna SAA
Glance View
Auna SAA is a Peru-based private healthcare provider. It offers oncology healthcare plans in Peru and operates hospitals and clinics in Peru and Colombia, providing medical services at all levels of complexity. It operates through three segments Oncosalud Peru, Healthcare Services in Peru and Healthcare Services in Colombia. The Oncosalud Peru segment includes the prepaid oncology plans and related services provided at the facilities in Peru, as well as services provided under its prepaid plans and third-party healthcare plans, among others. The Healthcare Services segments in Peru and Colombia consist of healthcare services provided at any of its facilities, in Peru other than those in the Oncosalud network. The Company's network is horizontally integrated, meaning that patients can access all their treatment, diagnostic imaging, laboratory and pharmaceutical needs at one of its facilities instead of having to go to different providers for each service.
